Phase Forward is a leading provider of integrated data collection and data-management solutions for clinical trials and drug safety. Its award-winning technology and global services are designed to enable life-sciences companies of all types and sizes to automate and integrate the management of their entire clinical development process — from study initiation and FDA submission through post-marketing studies. Phase Forward's products and services have been used in more than 10,000 clinical trials involving more than 1 million trial study participants at more than 250 life-sciences companies, medical-device firms, regulatory agencies and public-health organizations.
The Massachusetts-based company — with international headquarters in Maidenhead, U.K. — expanded its product offerings when it acquired Vermont's Green Mountain Logic last October. The Montpelier office is focused on the LabPas product suite, a groundbreaking software platform providing substantial improvements in quality, efficiency and speed for Phase I clinical drug trials and life-science laboratories.